Simmons & Simmons' Paris office has announced the hire of Isabelle Meyrier as a new partner. She joins the Private Equity team within the Corporate Commercial (CoComm) department, led by Jérôme Patenotte. This key hire underscores the firm's commitment to bolstering its Private Equity market presence and broadening its industry expertise. Isabelle's arrival, following Pascal Jouannic's in November, signals Simmons' ongoing expansion in Paris.

Boasting over two decades of experience, Isabelle is a distinguished Private Equity expert. She has a track record of guiding clients through intricate mergers and acquisitions, mid-cap Leveraged Buyouts (LBO), and Venture Capital initiatives. Additionally, she brings deep knowledge in the health and life sciences sector, aligning with Simmons' long-standing strategic focus in Paris.

Isabelle Meyrier states, I am delighted to join Simmons & Simmons, and its expanding, dynamic office in Paris. I look forward to contributing to the development of the firm's Private Equity practice and to forging connections with the Health and Life Sciences teams, whose reputation is well established, to cater to the surging market demand for health sector companies and investment funds, especially in Venture Capital and Growth Equity.

Jacques-Antoine Robert, Managing Partner at the Paris office, adds, We are thrilled about Isabelle’s arrival at Simmons, which marks an important step in our development. Her experience and reputation in the Private Equity market are valuable assets for our firm. Her joining will not only solidify our health sector standing but also facilitate strategic synergies with our partners, including Simonetta Giordano, Alexandre Regniault, Julien Moiroux, and Jérôme Patenotte.

Isabelle Meyrier graduated from King’s College London and holds a dual master's degree in French and English law from the University of Panthéon-Sorbonne. She began her career at PDGB before joining the Private Equity team at King & Wood Mallesons (formerly SJ Berwin) in 2005, and then moved to Goodwin in 2016, along with the same team. Most recently, she held the position of Legal Director at the investment fund JEITO, specializing in biotechnologies, where she developed her expertise in Health and Life Sciences.

This news story was originally published on the firm’s website.